Search results for #CROI2024
La Noticia del Día de @gTtVIH: La profilaxis preexposición al VIH a demanda podría ser la mejor opción en mujeres #CROI2024 gtt-vih.org/publicaciones/…
La Noticia del Día: La profilaxis preexposición al VIH a demanda podría ser la mejor opción en mujeres #CROI2024 gtt-vih.org/publicaciones/… vía @gTtVIH
La Noticia del Día de @gTtVIH: La profilaxis preexposición al VIH a demanda podría ser la mejor opción en mujeres #CROI2024 gtt-vih.org/publicaciones/…
Interesting findings from a #VERDI study on #COVID19 in immunocompromised (IC) kids show that: 📌 IC kids have similar/lower risk of #SARSCoV2 infection than non-IC kids 📌 Severe #COVID cases are rare!😀 View presentation by @C_DiChiara_MD at #CROI2024👉 verdiproject.org/wp-content/upl…
Tune in Tuesday 👇as we discuss some of the most exciting research coming out of #CROI2024! The SEARCH Dynamic Choice study offered oral #PrEP, PEP or injectable cabotegravir to both men and women, and an option to switch products. Join us to learn more, avac.org/event/search-d…
Study results suggest that HIV-positive people may benefit from cholesterol and blood pressure management at lower thresholds. #cardiovascular #cholesterol #CROI2024 #heartattack #highbloodpressure #hypertension #statin #stroke poz.com/article/cardio…
La Noticia del Día de @gTtVIH: La crisis de los opioides en EE UU ha alcanzado a las personas mayores con el VIH #CROI2024 gtt-vih.org/publicaciones/…
Next Tuesday, April 23 at 10AM ET! Join AVAC and the SEARCH team in conversation with @ProfKamya to discuss early results from the SEARCH Dynamic Study coming out of #CROI2024 and the role choice plays in #HIV prevention. Register and learn more here! 🌟 avac.org/event/search-d…
One month since wrapping up at #CROI2024! Thrilled to have presented results from two studies on #COVID-19 severity in IC children conducted in Italy and Canada! Grateful for the networking opportunities and eager for future collaborations! @SickKidsGlobal @Penta_ID #PedID
Dr. Yendewa spoke at the AFC Community Briefing today, about research news presented at #CROI2024 . 💜 We are grateful to Julie Patterson for the opportunity to be involved and to talk about our NIH-funded clinical trials.
Early hypertension treatment showed promising results in reducing mean systolic blood pressure and the incidence of hypertension in people living with HIV, according to findings presented at #CROI2024. bit.ly/3VMyOIG
Insights from #CROI2024: Dr. Sarah A. Cooley's study explores the effects of air pollution on cognition and inflammation in people living with HIV, shedding light on the importance of environmental factors in health outcomes. bit.ly/4cjusP6
La Noticia del Día de @gTtVIH: Un inicio tardío del tratamiento antirretroviral aumentaría el riesgo de eventos clínicos graves durante años #CROI2024 gtt-vih.org/publicaciones/…
La Noticia del Día de @gTtVIH: Un inicio tardío del tratamiento antirretroviral aumentaría el riesgo de eventos clínicos graves durante años #CROI2024 gtt-vih.org/publicaciones/…
#NoticiasVIH vía @gTtVIH: #CROI2024: ¿Cuál es la causa principal del aumento de peso tras iniciar el tratamiento antirretroviral por primera vez? gtt-vih.org/publicaciones/…
A must watch: @DrJeanneM’s talk at #CROI2024 shed light on the ongoing efforts in #HIVResearch: Prevention approaches, emerging antiretroviral therapies, and the evolving landscape of #HIV epidemiology. bit.ly/3vdqXc6
